Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...

Shielding against radiation will not only help people survive nuclear fallout but also improve health outcomes for cancer ...

A new report shows while cancer death rates among Black people are declining, they remain higher than other racial and ethnic ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

The global radiation therapy market size is calculated at USD 7.86 billion in 2025 and is expected to reach around USD 12.93 ...

Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...

Investigators report that estradiol works as well as luteinizing hormone–releasing hormone agonists for testosterone suppression and have a much better side-effect profile.